[Factors related to adjuvant ovarian function suppression in premenopausal breast cancer patients].

医学 依西美坦 三苯氧胺 乳腺癌 内科学 妇科 肿瘤科 佐剂 癌症
作者
Yue Liang,Xiaosong Chen,Jiayi Wu,Ou Huang,Yu Zong,Lijing Nie,Qiong Fang,Jian-Rong He,Li Zhu,Weiguo Chen,Yafen Li,Kunwei Shen
出处
期刊:Chinese journal of oncology [BioMed Central]
卷期号:38 (5): 357-62
标识
DOI:10.3760/cma.j.issn.0253-3766.2016.05.007
摘要

To analyze the applied condition of ovary function suppression (OFS) before and after joint analysis of TEXT and SOFT trials and SOFT trial, and to identify the relevant factors of OFS usage.The analysis was performed in premenopausal women with hormone receptor (HR) positive breast cancer receiving surgical treatment from Apr 2013 to Oct 2015 in Ruijin Hospital, Shanghai Jiaotong University School of Medicine. Adjuvant treatment strategy was made in the multidisciplinary team (MDT) meetings. We analyzed the applied condition of OFS before and after joint analysis, SOFT trial and its relevant factors.Among 454 patients, 114 (25.1%) patients received OFS. Before the results of joint analysis came out, all the patients (38/38) received OFS together with tamoxifen (TAM); after the results came out, clinicians began to put OFS with exemestane into practice, among 76 patients, 41(53.9%) patients received OFS with exemestane while 35 (46.1%) patients received OFS together with TAM. Before the results of SOFT trial came out, 71 out of 310 (22.9%) patients received OFS while 43 out of 144 (29.9%) patients received OFS after that. No significant difference was found between the proportion of patients receiving OFS before and after the results of SOFT trial came out (P=0.112). Age, histological grade, pN status, Ki-67 status, molecular subtype and acceptance of chemotherapy were correlated with OFS treatment (P<0.05). Age, tumor grade and pN were independent significant predictors of OFS usage.After the results of joint analysis came out, clinicians began to apply OFS with exemestane to premenopausal women with HR positive breast cancer. There is no significant difference between the proportion of patients receiving OFS before and after SOFT trial. Age, tumor grade and pN status are independent significant predictors of OFS treatment. Patients younger than 40, with histological grade Ⅱ or Ⅲ tumor and with pN1 or pN2 status are prone to receive OFS.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
生动枫完成签到,获得积分10
2秒前
向往完成签到 ,获得积分10
5秒前
cc完成签到,获得积分10
6秒前
轻松凌柏完成签到 ,获得积分10
8秒前
Lutte001完成签到,获得积分10
8秒前
幽默的煎饼完成签到,获得积分10
9秒前
10秒前
huoguo完成签到,获得积分10
12秒前
lgf完成签到,获得积分10
13秒前
xiaofan完成签到,获得积分10
14秒前
KX2024完成签到,获得积分10
14秒前
14秒前
dywtdw发布了新的文献求助10
15秒前
西哥完成签到,获得积分10
15秒前
王青文完成签到,获得积分10
16秒前
满意涵梅完成签到 ,获得积分10
17秒前
123456789完成签到 ,获得积分10
17秒前
小王小王完成签到,获得积分10
18秒前
songyl完成签到,获得积分10
23秒前
23秒前
zhangyuting完成签到 ,获得积分10
25秒前
25秒前
开心晓灵关注了科研通微信公众号
28秒前
Brian完成签到,获得积分10
32秒前
coco完成签到,获得积分10
35秒前
Camellia完成签到,获得积分10
36秒前
于你无瓜完成签到 ,获得积分10
36秒前
YUNI完成签到 ,获得积分10
36秒前
蒋鑫淼应助武雨寒采纳,获得10
36秒前
Wesley完成签到,获得积分10
37秒前
少吃一口完成签到,获得积分10
40秒前
微笑语雪完成签到,获得积分10
42秒前
Yurrrrt完成签到,获得积分10
46秒前
Jerry完成签到 ,获得积分10
47秒前
微笑语雪发布了新的文献求助10
50秒前
SerCheung完成签到,获得积分10
50秒前
Linky完成签到 ,获得积分10
51秒前
六月完成签到,获得积分10
51秒前
daqi完成签到,获得积分10
52秒前
53秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
PowerCascade: A Synthetic Dataset for Cascading Failure Analysis in Power Systems 2000
Picture this! Including first nations fiction picture books in school library collections 1000
Signals, Systems, and Signal Processing 610
Unlocking Chemical Thinking: Reimagining Chemistry Teaching and Learning 555
Photodetectors: From Ultraviolet to Infrared 500
Cancer Targets: Novel Therapies and Emerging Research Directions (Part 1) 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6359063
求助须知:如何正确求助?哪些是违规求助? 8173036
关于积分的说明 17212284
捐赠科研通 5414057
什么是DOI,文献DOI怎么找? 2865382
邀请新用户注册赠送积分活动 1842737
关于科研通互助平台的介绍 1690901